Search results : University College London Hospitals NHS Foundation Trust

Page results

Treatment options for iron overload
Managing dislocations and subluxations

Joint dislocations and subluxations can commonly occur in patients diagnosed with hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD). Such events can be very…
What to Expect After Congenital Cytomegalovirus Diagnosis

This page has been written for parents of children who have been diagnosed with congenital cytomegalovirus (cCMV) infection.
COVID-19 information for patients and visitors

COVID-19 information for patients and visitors Patients Please continue to attend hospital if you have an appointment or a medical emergency. If you need emergency treatment for symptoms…
Carbohydrate counting using cup measures
Sexual health, contraception and preparing for pregnancy: Information for patients with thalassaemia and sickle cell disorder
Information for the “Small Baby Clinic” at UCLH

This page has been written for women and families who use the UCLH Small Baby Clinic.
Priapism in patients with sickle cell disorder
Medications, vaccinations and travel in thalassaemia
Hydroxyurea for treatment of sickle cell disorder

Ref no FOI.2023.0542 Response

FOI/2023/0542 - Pulmonary rehabilitation (PR)
Ref no FOI.2023.0537 Response

FOI/2023/0537 - Agency usage for the Occupational Therapy
Ref no FOI.2023.0523 Response

FOI/2023/0523 - Treatment on Nivolumab
Ref no FOI.2023.0505 Response

FOI/2023/0505 - Telecommunications infrastructure contract
Ref no FOI.2023.0493 Response

FOI/2023/0493 - Treatments for various diseases
Ref no FOI.2023.0497 Response

FOI/2023/0497 - List of all laboratories within Pathology
Ref no FOI.2023.0499 Response

FOI/2023/0499 - Treatments for non-small cell lung cancer
Ref no FOI.2023.0500 Response

FOI/2023/0500 - Treatment of urothelial and colorectal cancer
Ref no FOI.2023.0501 Response

FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
Ref no FOI.2023.0509 Response

FOI/2023/0509 - Immunoglobulin treatments

Was this page helpful? Let us know